S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02%

Next Bullish Trade

Sign in

Account

Create free accountFree dashboard, no payment Sign inEmail yourself a login link CoursesYour library & catalog

PCSA

Processa Pharmaceuticals, Inc. NCM · PCSA

$2.31 +0.07 (+3.12%)

Neutral · +0.64σ

+ Compare Open in Sniper

News · PCSA

Full news feed →

Gastroparesis Market Poised for Extraordinary Growth at a 21.9% CAGR in the US by 2034 Due to the Launch of Novel MoAs Such as NK-1R Antagonists, 5-HT4 Receptor Agonists, D2 Receptor Antagonists, and Others | DelveInsight

GlobeNewswire Inc. · 264d ago

Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight?

Benzinga · 283d ago

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

GlobeNewswire Inc. · 414d ago

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference

GlobeNewswire Inc. · 526d ago

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire Inc. · 534d ago

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September

GlobeNewswire Inc. · 683d ago

Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer

GlobeNewswire Inc. · 767d ago

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference

GlobeNewswire Inc. · 803d ago

Spotting Penny Stocks Uptrends, 3 Top Tips

PennyStocks · 813d ago

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

GlobeNewswire Inc. · 842d ago

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

GlobeNewswire Inc. · 845d ago

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

GlobeNewswire Inc. · 885d ago

Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying

Benzinga · 891d ago

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

GlobeNewswire Inc. · 893d ago

Expensify And 3 Other Stocks Under $3 Insiders Are Buying

Benzinga · 897d ago

Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results

Benzinga · 904d ago

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga · 904d ago

Crude Oil Down 1%; American Express Shares Rise After Q4 Results

Benzinga · 904d ago

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

GlobeNewswire Inc. · 904d ago

Nasdaq Edges Lower; American Airlines Posts Upbeat Earnings

Benzinga · 905d ago

Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results

Benzinga · 905d ago

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses

GlobeNewswire Inc. · 905d ago

US Stocks Higher; Nasdaq Jumps 100 Points

Benzinga · 908d ago

S&P 500 Gains 1%; State Street Reports Upbeat Earnings

Benzinga · 911d ago